Market Value349,550,312
Total Holdings90
File Date2023-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCAB / BioAtla, Inc.
SDGR / Schrödinger, Inc.
CUE / Cue Biopharma, Inc.
GSK / GSK plc - Depositary Receipt (Common Stock)
BRZE / Braze, Inc.
DSGN / Design Therapeutics, Inc.
STXS / Stereotaxis, Inc.
ATXS / Astria Therapeutics, Inc.
ELOX / Eloxx Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc.
ALLK / Allakos Inc.
MRSN / Mersana Therapeutics, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
AXSM / Axsome Therapeutics, Inc.
IMTX / Immatics N.V.
MGTX / MeiraGTx Holdings plc
CDXS / Codexis, Inc.
MRTX / Mirati Therapeutics, Inc.
ITCI / Intra-Cellular Therapies, Inc.
PHR / Phreesia, Inc.
MRTX / Mirati Therapeutics, Inc. Call
UTHR / United Therapeutics Corporation
EYPT / EyePoint Pharmaceuticals, Inc.
NCNA / NuCana plc - Depositary Receipt (Common Stock)
PYPD / PolyPid Ltd. Put
PRTA / Prothena Corporation plc Put
XENE / Xenon Pharmaceuticals Inc.
BIIB / Biogen Inc.
MCRB / Seres Therapeutics, Inc.
ALT / Altimmune, Inc. Call
SGEN / Seagen Inc
RXDX / Prometheus Biosciences Inc
ORIC / ORIC Pharmaceuticals, Inc.
RGNX / REGENXBIO Inc.
IMVT / Immunovant, Inc.
RXDX / Prometheus Biosciences Inc Put
IMGN / ImmunoGen, Inc.
IMGN / ImmunoGen, Inc. Call
BLU / Bellus Health Inc
ABOS / Acumen Pharmaceuticals, Inc.
CVRX / CVRx, Inc.
CLNN / Clene Inc. Put
NKTX / Nkarta, Inc.
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
APEN / Apollo Endosurgery Inc
ARVN / Arvinas, Inc.
KRTX / Karuna Therapeutics, Inc.
US03217L1061 / Amryt Pharma PLC Sponsored ADR (United Kingdom)
CGEM / Cullinan Therapeutics, Inc.
/ BRICKELL BIOTECH INC
KYG5960S1241 / Medicus Sciences Acquisition Corp.
HZNP / Horizon Therapeutics Plc
ISEE / IVERIC bio Inc Put
PRAX / Praxis Precision Medicines, Inc.
IMUX / Immunic, Inc.
ALT / Altimmune, Inc.
ESPR / Esperion Therapeutics, Inc.
PNT / POINT Biopharma Global Inc.
VRTX / Vertex Pharmaceuticals Incorporated
CYTK / Cytokinetics, Incorporated
AVXL / Anavex Life Sciences Corp. Call
BCRX / BioCryst Pharmaceuticals, Inc.
PHVS / Pharvaris N.V.
CTIC / CTI BioPharma Corp
ETNB / 89bio, Inc.
AKRO / Akero Therapeutics, Inc. Put
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
AKRO / Akero Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc. Call
ELOX / Eloxx Pharmaceuticals, Inc.
AVTE / Aerovate Therapeutics, Inc.
CINC / CinCor Pharma Inc
EVGN / Evogene Ltd.
TERN / Terns Pharmaceuticals, Inc.
VRAYQ / ViewRay, Inc.
KRYS / Krystal Biotech, Inc.
NGM / NGM Biopharmaceuticals, Inc.
VERU / Veru Inc. Put
AVXL / Anavex Life Sciences Corp. Put
LVTX / LAVA Therapeutics N.V.
ISEE / IVERIC bio Inc
COGT / Cogent Biosciences, Inc.
ACRS / Aclaris Therapeutics, Inc.
VCYT / Veracyte, Inc.
MDGL / Madrigal Pharmaceuticals, Inc. Put
CGEN / Compugen Ltd.
CLDX / Celldex Therapeutics, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
NTLA / Intellia Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
PRTA / Prothena Corporation plc
ELYM / Eliem Therapeutics, Inc.
MRUS / Merus N.V.
CERS / Cerus Corporation
CMPX / Compass Therapeutics, Inc.
MORF / Morphic Holding, Inc.
RLMD / Relmada Therapeutics, Inc. Put
CRNX / Crinetics Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
INSM / Insmed Incorporated
PLRX / Pliant Therapeutics, Inc.
QURE / uniQure N.V.
RNA / Avidity Biosciences, Inc.
TRVI / Trevi Therapeutics, Inc.
MGNX / MacroGenics, Inc.
GOSS / Gossamer Bio, Inc.
WVE / Wave Life Sciences Ltd.
PSTX / Poseida Therapeutics, Inc.